Free Insulin-like Growth Factor (IGF)-I in Children with PWS

In children with Prader–Willi syndrome (PWS), the standard growth hormone (GH) dose often results in high immunoreactive IGF-I levels. These high immunoreactive IGF-I levels lead to concern because their long-term effects are unknown. As a result, clinicians have to lower the GH dose, which worsens...

Descripción completa

Detalles Bibliográficos
Autores principales: Damen, Layla, Elizabeth, Melitza S. M., Donze, Stephany H., van den Berg, Sjoerd A. A., de Graaff, Laura C. G., Hokken-Koelega, Anita C. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911349/
https://www.ncbi.nlm.nih.gov/pubmed/35268371
http://dx.doi.org/10.3390/jcm11051280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911349/
https://www.ncbi.nlm.nih.gov/pubmed/35268371
http://dx.doi.org/10.3390/jcm11051280

Ejemplares similares